Results 201 to 210 of about 39,017 (214)

Personalized medicine for clopidogrel resistance?

Nature Reviews Cardiology, 2009
Jean-Sébastien Hulot, Valentin Fuster
openaire   +1 more source

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Lancet, The, 2001
Salim Yusuf, Basil S Lewis
exaly  

Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

Lancet, The, 2010
Lars Wallentin, Stefan James, Robert F Storey   +2 more
exaly  

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

Lancet, The, 2010
Stefan James, Hugo A Katus, Mátyás Keltai   +2 more
exaly  

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

Lancet, The, 2010
Jean-Francois Tanguay, John W. Eikelboom, Christopher B Granger   +2 more
exaly  

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

Lancet, The, 2010
Tabassome Simon, Marc S Sabatine
exaly  

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

Lancet, The, 2018
Philip M W Bath, Lisa J Woodhouse, Hanne Christensen   +2 more
exaly  

Aspirin and Clopidogrel

Arteriosclerosis, Thrombosis, and Vascular Biology, 2004
Marco Cattaneo
exaly  

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

Lancet, The, 1996
exaly  

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Lancet, The, 2006
exaly